Authors: Sinclair, SE Frighetto, L Loewen, PS Sunderji, R Teal, P Fagan, SC Marra, CA

Citation: Se. Sinclair et al., Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke - A Canadian healthcare perspective, PHARMACOECO, 19(9), 2001, pp. 927-936

Authors: Sunderji, R Kanji, Z Gin, K

Citation: R. Sunderji et al., Pulmonary effects of low dose amiodarone: A review of the risks and recommendations for surveillance, CAN J CARD, 16(11), 2000, pp. 1435-1440

Authors: Sunderji, R Campbell, L Shalansky, K Fung, A Carter, C Gin, K

Citation: R. Sunderji et al., Outpatient self-management of warfarin therapy: A pilot study, PHARMACOTHE, 19(6), 1999, pp. 787-793

Authors: Kanji, Z Sunderji, R Gin, K

Citation: Z. Kanji et al., Amiodarone-induced pulmonary toxicity, PHARMACOTHE, 19(12), 1999, pp. 1463-1466